资产 更改
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Immunic USD 189.74M 165.69M 2026-03
Insmed USD 2.1B 26.7M 2026-06
Omeros USD 200.57M 34.59M 2025-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Quidel USD 5.72B 86.6M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06